Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Bibliographic Details
Title: Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Authors: Shrotri, Madhumita, Krutikov, Maria, Palmer, Tom, Giddings, Rebecca, Azmi, Borscha, Subbarao, Sathyavani, Fuller, Christopher, Irwin-Singer, Aidan, Davies, Daniel, Tut, Gokhan, Lopez Bernal, Jamie, Moss, Paul, Hayward, Andrew, Copas, Andrew, Shallcross, Laura *
Source: In The Lancet Infectious Diseases November 2021 21(11):1529-1538
Database: ScienceDirect
More Details
ISSN:14733099
DOI:10.1016/S1473-3099(21)00289-9
Published in:The Lancet Infectious Diseases
Language:English